Based on this knowledge, our hypothesis was that CD4+CD25+ FOXP3+ Tregs, CD200, and PD-1 would have higher levels of expression in MM patients that underwent APBSCT.
All of the APBSCT patients received the same mobilization protocol, which included high-dose cyclophosphamide.
The clinical and histological features of the patients that did [APBSCT (+)] and did not [APBSCT (-)] undergo APBSCT are shown in Tables 1 and 2, respectively.
Clinical and histological features of the APBSCT (+) cases (n = 1) Gender Female 5 45.
07% and 9% in the APBSCT (+) cases, and between 0% and 11% in the APBSCT (-) cases.
Flow cytometry results for CD4+ T-cells, CD4 + CD25 + FPXP3 + Tregs, and PD-1 + and CD200 + T-cells APBSCT Patient no.
The level of CD4+ Tregs identified according to CD4+CD25+FOXP3+ was higher in the APBSCT (+) patients (p=0.